What Alignment Healthcare, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 8 | 80 |
| Total trades | 8 | 105 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 1,413,559 |
| Disposed | 1,066,967 | 5,962,315 |
| Net activity | −1,066,967 | −4,548,756 |
Common stock only — 2 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kim Hyong | Chief Medical Officer | Oct 06 | Open-market sale · S | −32,479 | $8.30 | −$270K | 299,271 |
| Konowiecki Joseph S | EVP, Corporate Affairs | Sep 17 | Sale for tax withholding · S | −23,511 | $8.61 | −$202K | 1,080,305 |
| Kao John E | Chief Executive Officer | Sep 14 | Open-market sale · S | −27,400 | $13.00 | −$356K | 590,766 |
| Kao John E | Chief Executive Officer | Sep 11 | Sale for tax withholding · S | −385,270 | $12.68 | −$4.89M | 1,223,473 |
| Maroney Dawn Christine | President | Sep 11 | Sale for tax withholding · S | −122,707 | $12.68 | −$1.56M | 794,606 |
| Kao John E | Chief Executive Officer | Sep 10 | Open-market sale · S | −172,600 | $12.96 | −$2.24M | 618,166 |
| Maroney Dawn Christine | President | Aug 14 | Open-market sale · S | −5,000 | $14.00 | −$70K | 917,313 |
| Kao John E | Chief Executive Officer | Aug 10 | Open-market sale · S | −298,000 | $13.88 | −$4.14M | 790,766 |
| Maroney Dawn Christine | President | Jul 15 | Open-market sale · S | −177,068 | $20.83 | −$3.69M | 922,313 |
| Maroney Dawn Christine | President | Jul 15 | Exercise / conversion · M | +152,068 | $9.06 | +$1.38M | 1,099,381 |
| Kao John E | Chief Executive Officer | Jul 10 | Open-market sale · S | −18,356 | $20.65 | −$379K | 1,088,766 |
| Kao John E | Chief Executive Officer | Jul 10 | Open-market sale · S | −279,644 | $19.81 | −$5.54M | 1,107,122 |
| Hochradel Shane J. | Chief Operations Officer | Jul 01 | Grant / award · A | +87,719 | — | — | 87,719 |
| Konowiecki Joseph S | EVP, Corporate Affairs | Jul 01 | Open-market sale · S | −25,000 | $24.00 | −$600K | 1,103,816 |
| Konowiecki Joseph S | EVP, Corporate Affairs | Jun 26 | Open-market sale · S | −25,000 | $23.00 | −$575K | 1,128,816 |
| Konowiecki Joseph S | EVP, Corporate Affairs | Jun 18 | Open-market sale · S | −25,000 | $22.00 | −$550K | 1,153,816 |
| Maroney Dawn Christine | President | Jun 15 | Open-market sale · S | −30,000 | $19.55 | −$586K | 947,313 |
| Kim Hyong | Chief Medical Officer | Jun 12 | Open-market sale · S | −35,951 | $19.86 | −$714K | 331,750 |
| Konowiecki Joseph S | EVP, Corporate Affairs | Jun 11 | Open-market sale · S | −25,000 | $21.00 | −$525K | 1,178,816 |
| Kao John E | Chief Executive Officer | Jun 10 | Open-market sale · S | −223,064 | $20.60 | −$4.59M | 1,386,766 |
Loading...
